Criteria of IFN treatment for chronic hepatitis C
Yano, M.
Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Suppl (Part 1): 986-990
1995
ISSN/ISBN: 0047-1852 PMID: 7563915 Document Number: 450470
Document emailed within 1 workday
Related Documents
Gunji, T.; Omata, M. 2004: Treatment and selection criteria for chronic hepatitis B Nihon Rinsho. Japanese Journal of Clinical Medicine 62 Suppl. 8: 309-312Rodrigo Sáez, L.; Vivas Alegre, S.; Palacio Galán, M.A.; Pérez Alvarez, R.; Rodríguez García, M. 1997: Associated autoimmune hepatitis and chronic hepatitis C virus infection: diagnostic and therapeutic criteria Gastroenterologia y Hepatologia 20(1): 43-44
Lobello, S.; Lorenzoni, U.; Vian, A.; Floreani, A.; Brunetto, M.R.; Chiaramonte, M. 1998: Interferon treatment in hepatitis B surface antigen-positive hepatitis B e antibody-positive chronic hepatitis B: role of hepatitis B core antibody IgM titre in patient selection and treatment monitoring Journal of Viral Hepatitis 5(1): 61-66
Carotti, A. 1980: Active chronic hepatitis. Criteria adopted and results in recent specialist studies Minerva Medica 71(47): 3429-3434
Levi, D.; Tanno, H.; Descalzi, V. 2006: Criteria to hepatitis C treatment response Acta Gastroenterologica Latinoamericana 36(Suppl 1): S50
Pani, A. 1975: Current views concerning chronic hepatitis in regard to the histopathological approach, criteria of etiopathogenesis, diagnosis, prognosis and therapy La Clinica Terapeutica 73(2): 103-112
Baba, T.; Makino, R.; Shibata, M.; Harada, E.; Mitamura, K. 1997: Interferon treatment for hepatitis G virus infection in patients with chronic hepatitis C Nihon Rinsho. Japanese Journal of Clinical Medicine 55(3): 625-630
Teuber, G.; Dienes, H.P.; Meyer zum Büschenfelde, K.H.; Gerken, G. 1995: Hepatitis B virus superinfection in a patient with chronic hepatitis C receiving alpha-interferon treatment Hepato-Gastroenterology 42(2): 189-191
Xu, J.-h.; Yu, Y.-y.; Si, C.-w.; Chen, X.-y.; Han, Z.-h.; Chen, Y.; Li, X.-y. 2009: A clinical study of viral dynamic change in patients with hepatitis B e antigen positive chronic hepatitis B by lamivudine treatment Zhonghua Yi Xue Za Zhi 89(41): 2902-2905
Eisenburg, J. 1995: Differential diagnosis of hepatitis A, B, C, D and E. Clinical, biochemical and virus serologic criteria. 4: Hepatitis D serology Fortschritte der Medizin 113(3): 35-36
Eisenburg, J. 1995: Differential diagnosis of hepatitis A, B, C, D and E. Clinical, biochemical and virus serologic criteria. 5: Hepatitis C serology Fortschritte der Medizin 113(4): 41-42
Armignacco, O.; Andreoni, M.; Sagnelli, E.; Puoti, M.; Bruno, R.; Gaeta, G.Battista.; Perno, C.F.; Santantonio, T.A.; Bonfanti, P.; Bonora, S.; Borderi, M.; Castagna, A.; d'Arminio Monforte, A.; De Luca, A.; Grossi, P.; Guaraldi, G.; Maggiolo, F.; Mussini, C.; Sagnelli, C.; Tavio, M.; Torti, C.; Uberti-Foppa, C.; Andreoni, M.; Angarano, G.; Antinori, A.; Armignacco, O.; Carosi, G.; Chirianni, A.; Di Perri, G.; Galli, M.; Lazzarin, A.; Rizzardini, G.; Sagnelli, E.; Taliani, G. 2014: Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease new microbiologica 37(4): 423-438
Mamraeva, L.T. 1972: Some immunological criteria of the effectiveness of prodigiosan in the treatment of chronic cholecystitis Antibiotiki 17(1): 79-82
Tung, H.-D.; Lu, S.-N.; Lee, C.-M.; Wang, J.-H.; Chen, T.-M.; Hung, C.-H.; Huang, W.-S.; Changchien, C.-S. 2002: Antiviral treatment responses in patients with chronic hepatitis C virus infection evaluated by a third generation anti-hepatitis C virus assay Journal of Viral Hepatitis 9(4): 304-308
Hrycewycz, N.; Sandres, K.; Barange, K.; Pascal, J.P.; Izopet, J.; Payen, J.L. 2001: Eradication of hepatitis C virus after 3 months of interferon and ribavirin treatment in an a interferon non-responder patient with chronic hepatitis C Gastroenterologie Clinique et Biologique 25(11): 1041-1042
Pirotte, J.; Rauber, G.; Ruyters, L. 1972: Chronic persistent hepatitis and chronic active hepatitis. Correlations between the histological aspects, clinical picture, biological and immunological data Archives Francaises des Maladies de l'Appareil Digestif 61(1): 7-18
Sonnabend, W.; Kistler, G.S.; Thiel, G.; Zollinger, H.U.; Bianchi, L.; Enderlin, F.; Gudat, F.; Krech, U. 1974: Chronic focal glomerulonephritis and chronic persistent hepatitis following kidney transplantation. Detection of Hepatitis B and Epstein-Barr virus antigen Schweizerische Medizinische Wochenschrift 104(35): 1205-1217
Korba, B.E.; Cote, P.J.; Menne, S.; Toshkov, I.; Baldwin, B.H.; Wells, F.V.; Tennant, B.C.; Gerin, J.L. 2004: Clevudine therapy with vaccine inhibits progression of chronic hepatitis and delays onset of hepatocellular carcinoma in chronic woodchuck hepatitis virus infection Antiviral Therapy 9(6): 937-952
Rossi, P.L.; Alfano, G.; D'Onofrio, G.; Menichella, G.; Mango, G. 1986: Depletion lymphocytapheresis in chronic lymphocytic leukemias: criteria for predicting which patients will respond to treatment International Journal of Artificial Organs 9(1): 59-62
Vázquez Nieto, L.; Segura Méndez, N.H.; del Rivero, L.; Contreras Hernández, R.; Torres Salazar, A.B.; Graun Genesias, N.; Rodríguez Vivas, D.M.; Gutiérrez, S.; Guinto, P. 2001: Criteria for the diagnosis and treatment of chronic rhino-sinusitis in family medicine, otorhinolaryngology, and allergy services Revista Alergia Mexico 48(6): 163-167